Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years

被引：0
|
作者：
William Fusi-Rubiano
Chandoshi Mukherjee
Mark Lane
Marie D. Tsaloumas
Nicholas Glover
Andrej Kidess
Alastair K. Denniston
Helen E. Palmer
Avinash Manna
Rupal Morjaria
机构：
[1] Queen Elizabeth Hospital Birmingham,Ophthalmology Department
[2] University Hospitals Birmingham NHSFT,undefined
[3] Sandwell & West Birmingham NHS Trust,undefined
[4] Academic Unit of Ophthalmology,undefined
[5] Institute of Inflammation & Ageing,undefined
[6] University of Birmingham,undefined
来源：
BMC Ophthalmology | / 18卷
关键词：
Diabetic Macular Oedema; Iluvien; Diabetic Retinopathy; Fluocinolone Acetonide implant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] RETINAL THICKNESS RESULTS PRIOR AND FOLLOWING TREATMENT WITH 0.19 MG FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR DIABETIC MACULAR EDEMA
    Carneiro, Angela M.
    Meireles, Angelina
    Sousa, Joao
    Teixeira, Carla
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [32] Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy
    Lima-Fontes, Mario
    Leuzinger-Dias, Mariana
    Barros-Pereira, Ricardo
    Fernandes, Vitor
    Falcao, Manuel
    Falcao-Reis, Fernando
    Rocha-Sousa, Amandio
    Alves-Faria, Pedro
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (01) : 377 - 388
  • [33] Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months
    Moll-Udina, Aina
    Hernanz, Ines
    Sainz-de-la-Maza, Maite
    Pelegrin, Laura
    Coelho-Borges, Ana Isabel
    Pazos, Marta
    Adan, Alfredo
    Llorenc, Victor
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (11) : 4181 - 4195
  • [34] Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months
    Aina Moll-Udina
    Inés Hernanz
    Maite Sainz-de-la-Maza
    Laura Pelegrín
    Ana Isabel Coelho-Borges
    Marta Pazos
    Alfredo Adán
    Victor Llorenç
    International Ophthalmology, 2023, 43 : 4181 - 4195
  • [35] Real-world experience with fluocinolone acetonide intravitreal implant in patients with diabetic macular edema
    Capone, Luigi
    Airaghi, Pietro
    Aragona, Pasquale
    Castellino, Nicolo
    Cicinelli, Maria Vittoria
    Ciucci, Francesco
    Coppola, Michele
    De Gaetano, Cristiano
    Lattanzio, Rosangela
    Lorusso, Massimo
    Maceroni, Martina
    Malvasi, Maria Elena
    Marco, Luisa
    Marraffa, Michele
    Martini, Gaia
    Mastropasqua, Rodolfo
    Minnella, Angelo Maria
    Nikolopulou, Eleni
    Ortisi, Elina
    Pacella, Elena
    Papa, Vincenzo
    Pennesi, Claudio
    Reibaldi, Michele
    Rizzo, Stanislao
    Toto, Lisa
    Trombetta, Luigi
    Bandello, Francesco
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (06) : 1837 - 1842
  • [36] Diabetic macular edema outcomes in eyes treated with fluocinolone acetonide 0.2 μg/d intravitreal implant: real-world UK experience
    El-Ghrably, Ibraheem
    Steel, David H. W.
    Habib, Maged
    Vaideanu-Collins, Daniela
    Manvikar, Sridhar
    Hillier, Roxane J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (03) : 357 - 362
  • [37] First real world analysis of safety in 0.19 mg fluocinolone acetonide (FAc, ILUVIEN) implant treated eyes receiving supplemental ocular steroid injection for diabetic macular edema (DME)
    Gonzalez, Victor H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [38] Safety and efficacy of fluocinolone acetonide intravitreal implant (Iluvien®) in patients with chronic diabetic macular edema in a real-life setting
    Santos, Monica
    Campos, Antonio
    Neves, Arminda
    Alfaiate, Pedro
    Pereira, Joana
    Castro e Sousa, Joao Paulo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [39] Clinical efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: five-year real-world results
    Emilie Dobler
    Bashar Raouf Mohammed
    Randhir Chavan
    Peck Lin Lip
    Arijit Mitra
    Bushra Mushtaq
    Eye, 2023, 37 : 2310 - 2315
  • [40] Real-world outcomes from the 3-year European ILUVIEN (0.19 mg fluocinolone acetonide implant) RegIstry Safety Study (IRISS)
    Koch, Frank H. J.
    Chakravarthy, Usha
    Khoramnia, Ramin
    Taylor, Simon
    Bailey, Clare
    Sousa, Joao
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
12345